REGULATION OF MHC CLASS II GENES: Lessons from a Disease
- 1 April 1996
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 14 (1) , 301-331
- https://doi.org/10.1146/annurev.immunol.14.1.301
Abstract
▪ Abstract Precise regulation of major histocompatibility complex class II (MHC-II) gene expression plays a crucial role in the control of the immune response. A major breakthrough in the elucidation of the molecular mechanisms involved in MHC-II regulation has recently come from the study of patients that suffer from a primary immunodeficiency resulting from regulatory defects in MHC-II expression. A genetic complementation cloning approach has led to the isolation of CIITA and RFX5, two essential MHC-II gene transactivators. CIITA and RFX5 are mutated in these patients, and the wild-type genes are capable of correcting their defect in MHC-II expression. The identification of these regulatory factors has furthered our understanding of the molecular mechanisms that regulate MHC-II genes. CIITA was found to be a non-DNA binding transactivator that functions as a molecular switch controlling both constitutive and inducible MHC-II expression. The finding that RFX5 is a subunit of the nuclear RFX-complex has ...Keywords
This publication has 136 references indexed in Scilit:
- Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genesImmunology Today, 1995
- MHC class II signaling in B-cell activationImmunology Today, 1994
- YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes.The Journal of Experimental Medicine, 1994
- Structural and functional properties of the evolutionarily ancient Y‐box family of nucleic acid binding proteinsBioEssays, 1994
- Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcomeThe Journal of Pediatrics, 1993
- The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequenceHuman Immunology, 1993
- Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factorsHuman Immunology, 1989
- Regulation of Genes for HLA Class II Antigens in Cell Lines from Patients with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1988
- Quantitative variation in la antigen expression plays a central role in immune regulationImmunology Today, 1984
- Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigensThe Journal of Pediatrics, 1978